GYRE Gyre Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 7, 2026
$7,11
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$5,44rendah 52m
$9,42tinggi 52m
Kapitalisasi Pasar (MRQ)
$754M
P/E (TTM)
-35.5
EPS (TTM)
$-0.20
Pendapatan (TTM)
$119M
lencana Anda
Rentang 52M
$5–$9
Peringkat Analis
BUY
Target Harga
$19
P/E
-35.5
ROE
-28.3%
Margin Laba Bersih
-23.7%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
GYRE Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$7.11
Kapitalisasi Pasar (MRQ)
$754M
P/E (TTM)
-35.5
EPS (TTM)
$-0.20
Pendapatan (TTM)
$119M
ROE (TTM)
-28.3%
Rentang 52M
$5–$9
GYRE Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 31 Okt. 2023 | 1-for-15 | Terbalik |
| 13 Feb. 2017 | 1-for-15 | Terbalik |
| 21 Agu 2015 | 1-for-7 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$117M2017-12-31 → 2025-12-31
EPS$0.022021-12-31 → 2025-12-31
Arus Kas Bebas$-180.0K2016-12-31 → 2025-12-31
Margin bersih-23.7%2020-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | GYRE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -35.5rata-rata 5T ≈167.4 | ≈167.4 | · | · | |
| P/S (TTM) | 6.3rata-rata 5T ≈8.9 | ≈8.9 | 8.0 | Kurang nilai | |
| P/B (MRQ) | 7.0rata-rata 5T ≈-28.9 | ≈-28.9 | 3.2 | Terlalu mahal | |
| Harga / FCF (TTM) | -47.9rata-rata 5T ≈-1214.5 | ≈-1214.5 | · | · | |
| Harga / Arus Kas (TTM) | -52.0rata-rata 5T ≈104.6 | ≈104.6 | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | 7.3rata-rata 5T ≈10.1 | ≈10.1 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | GYRE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -14.0%rata-rata 5T ≈-11.4% | ≈-11.4% | -1043.3% | Tingkat teratas | |
| Margin EBITDA (TTM) | -11.1%rata-rata 5T ≈-9.9% | ≈-9.9% | -1043.3% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | -13.5%rata-rata 5T ≈-11.2% | ≈-11.2% | · | · | |
| Margin Laba Bersih (TTM) | -23.7%rata-rata 5T ≈-16.7% | ≈-16.7% | -989.0% | Tingkat teratas | |
| ROA (TTM) | -16.1%rata-rata 5T ≈-20.7% | ≈-20.7% | -33.0% | Tingkat teratas | |
| ROE (TTM) | -28.3%rata-rata 5T ≈65.0% | ≈65.0% | -39.4% | Tingkat teratas | |
| ROIC | 7.4%rata-rata 5T ≈135.1% | ≈135.1% | -32.0% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | GYRE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 4.3rata-rata 5T ≈3.4 | ≈3.4 | 11.3 | Likuiditas rendah | |
| Rasio Cepat (MRQ) | 3.0rata-rata 5T ≈2.5 | ≈2.5 | 6.6 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | GYRE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 10.2%rata-rata 5T ≈248.7% | ≈248.7% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 4.5%rata-rata 5T ≈74.5% | ≈74.5% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 41.0% | · | · | · | |
| EPS YoY | -60.0% | · | · | · | |
| Net Income YoY (Laba Bersih YoY) | -44.8% | · | · | · | |
| EPS CAGR 3Y (CAGR EPS 3T) | -12.6% | · | · | · | |
| Net Income CAGR 3Y (CAGR Laba Bersih 3T) | 31.8% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | GYRE | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.8rata-rata 5T ≈0.9 | ≈0.9 | 0.0 | Tingkat teratas | |
| Receivables Turnover (Perputaran Piutang) | 4.6 | · | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$186.5K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
Pembayaran Tahunan≈$3.60
| Tanggal ex-dividen | Jumlah | Mata Uang | Imbal Hasil |
|---|---|---|---|
| Jan 13, 2023 | $3,60 | USD | ≈642.3% |
| Sep 21, 2022 | $21,45 | USD | ≈286.0% |
| Agu 20, 2015 | $896,18 | USD | ≈59.3% |
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
13.3%
Laporan Berikutnya
Nov 05, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 18, 2026 | $-0.12 | $-0.09 | -30.7% |
| 31 Maret 2026 | Mei 8, 2026 | $-0.10 | $-0.07 | -33.7% |
| 31 Des. 2025 | $0.05 | $0.06 | -13.5% | |
| 30 Sep. 2025 | $0.08 | $0.03 | 194.1% | |
| 30 Juni 2025 | $0.02 | $0.03 | -34.6% | |
| 31 Maret 2025 | $0.03 | $0.03 | -2.0% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | · | · | $275.0K | |
| Cost of Revenue | $5M | $4M | $5M | $5M | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $102M | $109M | $97M | · | · | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $14M | · | $69M | $53M | $44M | $21M | $13M | $12M | $6M | $5M | |
| SG&A Expense | $21M | $16M | $15M | $17M | $19M | $16M | $13M | $12M | $10M | $9M | $10M | $4M | |
| Operating Expenses | $105M | $90M | $176M | $88M | $95M | $78M | $57M | $34M | $23M | $21M | $16M | $9M | |
| Operating Income | $11M | $16M | $-67M | $9M | $-88M | $-57M | $-57M | $-34M | $-22M | $-20M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1M | $23.0K | |
| Other Non-op | $-2M | $-2M | $-2M | · | $-78.0K | $-91.0K | $-39.0K | $2M | $-1.0K | $86.0K | $131.0K | $575.0K | |
| Pretax Income | $14M | $23M | $-77M | $9M | $-88M | · | · | · | · | · | · | $-29M | |
| Income Tax | $5M | $5M | $9M | $5M | · | · | · | · | · | · | · | $3M | |
| Net Income | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| EPS (Basic) | $0.06 | $0.14 | $-1.41 | $0.04 | $-2.87 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | · | · | · | · | · | · | · | |
| Shares (Basic) | 89,344,622 | 85,094,948 | 65,831,675 | 63,588,119 | 30,640,977 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 103,180,037 | 102,293,526 | 65,831,675 | 75,686,406 | 30,640,977 | · | · | · | · | · | · | · | |
| EBITDA | $14M | $18M | $-66M | $-8M | · | $-57M | $-57M | · | $-22M | $-20M | $-13M | $-29M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $12M | $34M | $25M | $44M | $30M | $15M | $31M | $14M | $10M | $29M | $2M | |
| Short-term Investments | $15M | $15M | · | · | $3M | $49M | $61M | $89M | $18M | $7M | $3M | $51M | |
| Receivables | $31M | $20M | $15M | · | $2M | $3M | $15M | · | · | · | · | $141.0K | |
| Inventory | $10M | $6M | $4M | $6M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $3M | · | $2M | $3M | $7M | $4M | $4M | $1M | $958.0K | $2M | $103.0K | |
| Other Current Assets | $1M | $1M | $1M | $843.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $149M | $65M | $57M | $50M | $51M | $90M | $96M | $124M | $39M | $38M | $69M | $2M | |
| PP&E (Net) | $28M | $24M | $23M | $18M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | |
| PP&E (Gross) | $39M | $29M | $28M | $22M | · | · | · | $671.0K | $2M | $2M | $6M | $8M | |
| Accum. Depreciation | $11M | $6M | $4M | $4M | · | · | $400.0K | $300.0K | $2M | $2M | $6M | $7M | |
| Intangibles | $5M | $273.0K | $273.0K | $297.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $3M | $995.0K | $3M | $472.0K | $528.0K | $257.0K | $543.0K | $128.0K | · | · | $12.0K | |
| Total Assets | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Accounts Payable | $1M | $108.0K | $355.0K | $122.0K | $6M | $6M | $4M | $1M | $747.0K | $837.0K | $939.0K | $249.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Current Liabilities | $24M | $20M | $20M | $12M | $14M | $18M | $29M | $5M | $9M | $22M | $38M | $2M | |
| Capital Leases | $2M | $885.0K | $199.0K | $121.0K | $408.0K | $981.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $7.0K | $49.0K | $55.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $31M | $27M | $38M | $13M | $15M | $19M | $30M | $5M | $9M | $22M | $38M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $91.0K | $86.0K | $77.0K | $64.0K | $31.0K | $22.0K | $12.0K | $12.0K | $6.0K | $1.0K | $1.0K | $34.0K | |
| Paid-in Capital | $173M | $136M | $68M | $33M | $444M | $391M | $327M | $323M | $204M | $164M | $162M | $7M | |
| Retained Earnings | $-113M | $-73M | $-86M | $7M | $-403M | $-315M | $-259M | $-203M | $-173M | $-148M | $-131M | $-116M | |
| AOCI | $-908.0K | $-3M | $-2M | $-392.0K | · | $5.0K | $34.0K | $-4.0K | · | $-1.0K | $1.0K | $4.0K | |
| Stockholders' Equity | $62M | $63M | $-16M | $43M | $41M | $76M | $68M | $120M | $31M | $16M | $31M | $-109M | |
| Liabilities + Equity | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Shares Outstanding | 91,314,007 | 86,307,544 | 76,595,616 | 63,588,119 | 31,409,707 | 22,097,820 | 12,040,835 | 11,954,528 | 6,081,230 | 801,756 | 762,005 | 370,944 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $1M | $290.0K | $138.0K | $146.0K | $149.0K | $173.0K | $389.0K | $470.0K | $680.0K | |
| Stock-based Comp | $7M | $831.0K | $7M | $13M | $3M | $4M | $3M | $3M | $863.0K | $635.0K | $326.0K | $244.0K | |
| Deferred Tax | $-1M | $-1M | $-834.0K | $-890.0K | · | · | · | · | · | · | · | $72.0K | |
| Amort. of Intangibles | $576.0K | $38.0K | $100.0K | $200.0K | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-17M | $-23M | $104M | $-26M | · | $-3M | $8M | · | $585.0K | $-3M | $-5M | $-6M | |
| Operating Cash Flow | $1M | $-4M | $26M | $11M | $-84M | $-55M | $-44M | $-29M | $-20M | $-18M | $-19M | $-6M | |
| CapEx | $1M | $2M | $9M | $5M | $839.0K | · | $64.0K | $376.0K | $23.0K | $468.0K | $272.0K | $4.0K | |
| Investing Cash Flow | $-474.0K | $-20M | $-20M | $-14M | $48M | $10M | $27M | $-71M | $-11M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Stock Issued | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | · | $296.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $82.0K | · | |
| Net Stock Activity | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | $-82.0K | $296.0K | |
| Dividends Paid | · | · | · | $45M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $2M | $-45M | $50M | $60M | $327.0K | $111M | $21M | · | · | · | |
| Net Change in Cash | $25M | $-22M | $8M | $-5M | $14M | $15M | $-16M | $11M | $-10M | $-19M | $28M | $-1M | |
| Taxes Paid | $6M | $9M | $6M | $6M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · | · | $-44M | · | $-20M | $-19M | $-19M | $-34M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-35M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 96.3% | 95.9% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 9.8% | 15.3% | -59.3% | · | · | -273.9% | · | · | · | · | · | -10805.1% | |
| Net Margin | 8.5% | 16.9% | -75.3% | · | · | -268.5% | · | · | · | · | · | -11862.9% | |
| Pretax Margin | 12.4% | 21.9% | -67.8% | · | · | · | · | · | · | · | · | -10596.0% | |
| EBITDA Margin | 12.0% | 16.8% | -58.3% | · | · | -273.2% | · | · | · | · | · | -10677.5% | |
| ROA | 6.8% | 14.8% | -84.9% | -19.6% | · | -58.2% | -49.4% | · | -55.6% | -31.5% | -40.7% | -25.3% | |
| ROE | 11.7% | 75.4% | 387.3% | -214.5% | · | -66.1% | -73.8% | · | -92.0% | -71.4% | 37.9% | -1073.6% | |
| ROIC | 7.4% | 19.7% | 471.8% | 41.4% | · | · | · | · | · | · | · | -30.5% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · | 5.0 | 3.3 | · | 4.5 | 1.7 | 1.8 | 37.1 | |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · | 4.6 | 3.2 | · | 3.7 | 0.8 | 0.9 | 36.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -9.3 | -1291.9 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 1.1 | · | · | 0.2 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.9 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | 6.1 | · | · | · | 2.3 | · | · | · | · | · | 1.3 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $0.73 | $-0.21 | $-0.57 | · | $3.44 | $5.68 | · | $5.06 | $20.04 | $2.75 | $3.23 | |
| Revenue / Share | $1.13 | $1.03 | $1.72 | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.01 | $-0.04 | $0.39 | $-1.05 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.41 | $0.14 | $0.44 | $0.57 | · | $1.37 | $1.28 | · | $2.38 | $12.80 | $2.55 | $1.67 | |
| Dividend / Share | · | · | · | $0.24 | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | · | · | · | $1.43 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 | $-1.46 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -6.8% | 10.9% | 1294.0% | -65.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 143.4% | 75.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | $248.0K | $248.0K | $275.0K | |
| Net Income TTM | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| Market Cap | $645M | $1.04B | $1.97B | $300M | · | $2.09B | $1.23B | · | $1.24B | $117M | $8.05B | $139.98B | |
| P/E | 353.0 | 242.0 | -18.2 | 265.0 | -4.8 | -64.8 | -70.0 | -81.1 | -140.1 | -100.2 | -482.4 | -2837.2 | |
| P/S | 5.5 | 9.9 | 17.3 | 2.9 | · | 99.8 | · | · | 1222.2 | 472.8 | 32458.2 | 509025.8 | |
| P/B | 6.1 | 16.5 | -124.3 | -13.8 | · | 27.5 | 18.0 | · | 40.4 | 7.3 | 256.2 | 1283.2 | |
| P / Tangible Book | 6.4 | 16.6 | · | 7.1 | 10.4 | 27.5 | · | · | · | · | · | · | |
| P / Cash Flow | 638.3 | -286.8 | 76.0 | -9.1 | · | -38.0 | -28.2 | · | -62.4 | -6.3 | -421.1 | -4059.5 | |
| P / FCF | -3581.5 | -175.3 | 113.3 | · | · | · | -28.2 | · | -62.3 | -6.2 | -415.1 | -4059.0 | |
| Dividend Yield | · | · | · | 15.0% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.28% | 0.41% | -5.5% | 0.38% | -21.0% | -1.5% | -1.4% | -1.2% | -0.71% | -1.0% | -0.21% | -0.04% | |
| Payout Ratio | · | · | · | -546.4% | · | · | · | · | · | · | · | · | |
| Annual Payout | · | · | · | $45M | · | · | · | · | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | $37M | $31M | $30M | $22M | $28M | $25M | $25M | $27M | $27M | $32M | $29M | $25M | · | · | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $1M | $894.0K | $1M | $958.0K | $770.0K | $979.0K | $1M | $1M | $1M | $1M | · | · | |
| Gross Profit | · | · | · | $29M | $26M | $21M | · | $25M | $24M | $26M | $26M | $31M | $28M | $24M | · | · | |
| R&D Expense | · | $7M | $5M | $2M | $8M | $3M | $4M | $3M | $3M | $2M | $5M | $3M | $4M | $3M | · | $803.0K | |
| SG&A Expense | $8M | $7M | $7M | $4M | $7M | $5M | $5M | $4M | $3M | $3M | $10M | $1M | $2M | $2M | $4M | $4M | |
| Operating Expenses | $43M | $32M | $41M | $22M | $32M | $20M | $30M | $20M | $21M | $18M | $118M | $18M | $23M | $17M | $119M | $5M | |
| Operating Income | $-14M | $-9M | $118.0K | $7M | $-2M | $2M | $665.0K | $4M | $3M | $8M | $-92M | $13M | $5M | $7M | $-22M | $-5M | |
| Other Non-op | $-943.0K | $29.0K | $-2M | $727.0K | $-488.0K | $107.0K | $-2M | $-75.0K | $-72.0K | $122.0K | $-237.0K | $-1M | $629.0K | · | · | $-1.0K | |
| Pretax Income | $-14M | $-9M | $-66.0K | $8M | $-2M | $5M | $772.0K | $4M | $6M | $12M | $-100M | $11M | $6M | $6M | $-23M | $-5M | |
| Income Tax | $-164.0K | $621.0K | $1M | $2M | $662.0K | $901.0K | $203.0K | $1M | $1M | $3M | $699.0K | $4M | $2M | $2M | $5M | $0 | |
| Net Income | $-14M | $-19M | $-1M | $6M | $-2M | $5M | $569.0K | $3M | $5M | $10M | $-101M | $8M | $4M | $4M | $-28M | $-5M | |
| EPS (Basic) | $-0.12 | $-0.10 | $-0.01 | $0.04 | $-0.02 | $0.03 | $0.00 | $0.01 | $0.04 | $0.09 | $-1.54 | $0.06 | $0.03 | $0.04 | $-0.98 | $-0.16 | |
| EPS (Diluted) | $-0.12 | $-0.10 | $-0.01 | $0.03 | $-0.03 | $0.00 | $0.00 | $0.01 | $0.01 | $0.03 | $-1.51 | $0.05 | $0.02 | $0.03 | $-0.99 | $-0.16 | |
| Shares (Basic) | 100,637,599 | 91,317,142 | · | 90,850,040 | 89,119,344 | 86,420,530 | · | 85,643,646 | 85,502,403 | 83,265,879 | · | 63,588,119 | 63,588,119 | 63,588,119 | · | 31,484,542 | |
| Shares (Diluted) | 100,637,599 | 91,344,584 | · | 103,971,546 | 89,203,138 | 101,970,672 | · | 102,640,373 | 102,205,888 | 102,594,197 | · | 78,904,324 | 78,904,324 | 78,921,366 | · | 31,484,542 | |
| EBITDA | · | $-9M | · | $7M | $2M | $3M | · | $4M | $3M | $8M | · | $-2M | $-3M | $181.0K | · | $-5M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $38M | $37M | $40M | $36M | $15M | $12M | $16M | $16M | $30M | $34M | $2M | $7M | $8M | $25M | $23M | |
| Short-term Investments | $14M | $12M | $15M | $20M | $18M | $15M | $15M | $9M | $9M | $8M | · | · | · | · | · | · | |
| Receivables | $28M | $23M | $31M | $26M | $25M | $20M | $20M | · | · | · | $15M | · | · | · | · | · | |
| Inventory | $11M | $11M | · | · | $9M | $8M | · | $6M | $6M | $5M | $4M | · | · | · | $6M | · | |
| Prepaid Expense | $8M | $4M | · | $3M | $3M | $8M | · | · | · | · | · | · | $697.0K | $915.0K | · | $2M | |
| Other Current Assets | · | · | $1M | · | · | · | $1M | $2M | $2M | $2M | $1M | · | · | · | $843.0K | · | |
| Current Assets | $122M | $92M | $102M | $99M | $91M | $68M | $65M | $55M | $54M | $63M | $57M | $5M | $8M | $14M | $50M | $30M | |
| PP&E (Net) | $27M | $24M | $24M | $24M | $23M | $24M | $24M | $24M | $24M | $24M | $23M | · | · | $1.0K | $18M | $124.0K | |
| PP&E (Gross) | $40M | $32M | $31M | $31M | $30M | $30M | $29M | $30M | $28M | $28M | $28M | · | · | · | $22M | · | |
| Accum. Depreciation | $13M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | · | · | · | $4M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $273.0K | $184.0K | $186.0K | $196.0K | $205.0K | · | · | · | $297.0K | · | |
| Other Non-current Assets | $7M | $5M | $2M | $5M | $5M | $6M | $3M | $3M | $1M | $802.0K | $995.0K | $168.0K | $168.0K | $168.0K | $3M | $168.0K | |
| Total Assets | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Accounts Payable | $1M | $265.0K | $124.0K | $556.0K | $71.0K | $122.0K | $108.0K | $303.0K | $271.0K | $330.0K | $355.0K | $158.0K | $5.0K | $16.0K | $122.0K | $41.0K | |
| Current Liabilities | $29M | $20M | $18M | $16M | $17M | $19M | $20M | $15M | $16M | $19M | $20M | $2M | $3M | $7M | $12M | $2M | |
| Capital Leases | $2M | $72.0K | $303.0K | $539.0K | $771.0K | $780.0K | $885.0K | $1M | $1M | $175.0K | $199.0K | · | · | · | $121.0K | · | |
| Other Non-current Liabilities | $70.0K | $1M | $1M | $1M | $1M | $1M | $7.0K | $2.0K | $47.0K | $48.0K | $49.0K | · | · | · | $55.0K | · | |
| Total Liabilities | $34M | $25M | $24M | $22M | $23M | $25M | $27M | $27M | $28M | $33M | $38M | $6M | $7M | $11M | $13M | $2M | |
| Common Stock | $106.0K | $91.0K | $91.0K | $91.0K | $91.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K | $77.0K | $37.0K | $37.0K | $37.0K | $64.0K | $31.0K | |
| Paid-in Capital | $241M | $175M | $172M | $167M | $161M | $138M | $136M | $134M | $134M | $133M | $68M | $385M | $385M | $385M | $33M | $400M | |
| Retained Earnings | $-138M | $-78M | $-68M | $-67M | $-70M | $-71M | $-73M | $-73M | $-74M | $-78M | $-86M | $-415M | $-413M | $-411M | $7M | $-370M | |
| AOCI | $1M | $586.0K | $-779.0K | $-2M | $-2M | $-2M | $-3M | $-946.0K | $-2M | $-2M | $-2M | · | · | · | $-392.0K | · | |
| Stockholders' Equity | $108M | $101M | $106M | $102M | $92M | $68M | $63M | $63M | $60M | $57M | $-16M | $4M | $-28M | $-26M | $43M | $29M | |
| Liabilities + Equity | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Shares Outstanding | 106,033,763 | 91,337,121 | 91,314,007 | 90,890,381 | 90,822,828 | 87,636,209 | 86,307,544 | 85,769,526 | 85,537,774 | 85,423,246 | 76,595,616 | 37,978,142 | 37,974,892 | 37,759,825 | 63,588,119 | 31,490,053 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $672.0K | $656.0K | $649.0K | $641.0K | $535.0K | $461.0K | $445.0K | $228.0K | $415.0K | $298.0K | $772.0K | $581.0K | $276.0K | $867.0K | $40.0K | |
| Stock-based Comp | $2M | $3M | $5M | $1M | $906.0K | $507.0K | $567.0K | $237.0K | $16.0K | $11.0K | $7M | $98.0K | $89.0K | $210.0K | $12M | $224.0K | |
| Amort. of Intangibles | $179.0K | $175.0K | $172.0K | $170.0K | $167.0K | $67.0K | $-80.5K | $10.0K | $8.5K | $100.0K | $-7.0K | $14.0K | $48.0K | $45.0K | · | · | |
| Other Non-cash | · | $10M | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-17M | $3M | $-6M | $5M | $2M | $-129.0K | $-3M | $2M | $-5M | $3M | $3M | $31M | $21M | $10M | $42M | $-7M | |
| CapEx | $262.0K | $178.0K | $144.0K | $668.0K | $256.0K | $122.0K | $-65.0K | $693.0K | $1M | $231.0K | $2M | $2M | $2M | $2M | · | · | |
| Investing Cash Flow | $10M | $-3M | $2M | $-1M | $-3M | $2M | $-2M | $-2M | $-8M | $-7M | $1M | $-26M | $-16M | $-8M | $-69M | $0 | |
| Stock Issued | · | · | · | · | $22M | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | $2M | $4M | $8M | · | · | |
| Financing Cash Flow | $-8.0K | $21.0K | $318.0K | $365.0K | $22M | $1M | $964.0K | $324.0K | $156.0K | $658.0K | $15M | $-1M | $-4M | $-8M | · | $-45M | |
| Net Change in Cash | $-6M | $431.0K | $-3M | $4M | $21M | $3M | $-4M | $-231.0K | $-14M | $-4M | $7M | $16M | $12M | $3M | $16M | $-52M | |
| Taxes Paid | · | $1M | $1M | $687.0K | $447.0K | $3M | $761.0K | $537.0K | $6M | $1M | $961.0K | $1M | $4M | $463.0K | · | · | |
| Free Cash Flow | · | $3M | · | · | · | $-251.0K | · | · | · | $3M | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 94.7% | 95.7% | 96.0% | · | 96.2% | 97.0% | 96.4% | · | · | · | · | · | · | |
| Operating Margin | · | -41.5% | · | 22.7% | 8.1% | 10.3% | · | 16.6% | 12.9% | 29.7% | · | · | · | · | · | · | |
| Net Margin | · | -43.8% | · | 19.4% | 5.9% | 16.9% | · | 11.2% | 18.0% | 36.6% | · | · | · | · | · | · | |
| Pretax Margin | · | -41.0% | · | 25.0% | 8.4% | 21.0% | · | 15.4% | 23.9% | 45.9% | · | · | · | · | · | · | |
| EBITDA Margin | · | -38.6% | · | 22.7% | 8.1% | 12.7% | · | 16.6% | 12.9% | 31.2% | · | · | · | · | · | · | |
| ROA | · | -6.8% | · | 4.2% | 1.1% | 3.0% | · | 4.2% | 6.8% | 14.1% | · | -7.7% | -5.2% | 0.88% | · | -8.9% | |
| ROE | · | -11.6% | · | 7.2% | 2.1% | 6.0% | · | 8.6% | 28.3% | 64.8% | · | -9.6% | -9.7% | 46.0% | · | -10.8% | |
| ROIC | · | -9.8% | · | 5.3% | 1.7% | 2.7% | · | 4.9% | 4.1% | 11.3% | · | -46.2% | 9.0% | -0.65% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.6 | · | 6.2 | 5.4 | 3.6 | · | 3.7 | 3.4 | 3.2 | · | 2.9 | 2.7 | 2.0 | · | 18.4 | |
| Quick Ratio | · | 3.7 | · | 5.4 | 4.7 | 2.6 | · | 1.7 | 1.6 | 1.9 | · | 1.2 | 2.5 | 1.2 | · | 14.0 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.4 | · | · | · | · | · | · | |
| Receivables Turnover | · | 1.0 | · | 2.3 | 2.0 | 2.1 | · | · | · | · | · | · | · | · | · | · |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.11 | · | $1.12 | $1.01 | $0.78 | · | $0.74 | $0.71 | $0.66 | · | $0.09 | $-0.75 | $-0.69 | · | $0.93 | |
| Revenue / Share | · | $0.25 | · | $0.29 | $0.26 | $0.22 | · | $0.25 | $0.24 | $0.26 | · | · | · | · | · | · | |
| Cash Flow / Share | · | $0.03 | · | · | · | $-0.00 | · | · | · | $0.03 | · | · | · | $-0.16 | · | · | |
| Cash / Share | · | $0.41 | · | $0.44 | $0.40 | $0.17 | · | $0.18 | $0.19 | $0.35 | · | $0.06 | $0.18 | $0.21 | · | $0.73 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.24 | · | $1.43 | |
| EPS (TTM) | $-0.22 | $-0.11 | · | $0.00 | $-0.02 | $0.02 | · | $-1.46 | $-1.42 | $-1.41 | · | $-0.89 | $-1.10 | $0.52 | · | $0.38 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $120M | · | $110M | $105M | $101M | · | $105M | $112M | $116M | · | · | · | · | · | · | |
| Net Income TTM | $-29M | $-16M | · | $9M | $6M | $13M | · | $-84M | $-79M | $-80M | · | $-12M | $-25M | $23M | · | $12M | |
| Market Cap | · | $637M | · | $678M | $668M | $677M | · | $1.08B | $1.02B | $1.49B | · | $273M | $199M | $119M | · | $236M | |
| P/E | -30.0 | -63.4 | · | · | -367.5 | 386.0 | · | -8.6 | -8.4 | -12.4 | · | -8.1 | -4.8 | 6.1 | · | 19.7 | |
| P/S | · | 5.3 | · | 6.2 | 6.3 | 6.7 | · | 10.2 | 9.1 | 12.9 | · | · | · | · | · | · | |
| P/B | · | 6.3 | · | 6.7 | 7.3 | 9.9 | · | 17.0 | 16.9 | 26.4 | · | 77.7 | -7.0 | -4.6 | · | 8.0 | |
| P / Tangible Book | 6.8 | 6.6 | · | 7.0 | 7.7 | 10.7 | · | 17.1 | 17.0 | 26.5 | · | 77.7 | · | · | · | 8.0 | |
| P / Cash Flow | · | 200.2 | · | · | · | -5244.6 | · | · | · | 517.8 | · | · | · | -19.1 | · | · | |
| Earnings Yield | -3.3% | -1.6% | · | 0.00% | -0.27% | 0.26% | · | -11.6% | -11.9% | -8.1% | · | -12.4% | -20.9% | 16.5% | · | 5.1% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | · | 2986.2% | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $117M | $106M | $113M | $102M | $7M |
| Margin Kotor % | · | 96.3% | 95.9% | · | · |
| Margin Operasi % | 9.8% | 15.3% | -59.3% | · | · |
| Laba Bersih | $10M | $18M | $-85M | $4M | $-88M |
| EPS Dilusian | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 5.6 | 3.3 | 2.9 | 1.7 | · |
| Rasio Cepat | 4.6 | 2.4 | 1.7 | 1.3 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-180.0K | $-6M | $17M | · | · |
Pemilik institusional (13F) 61 pengaju · $65.5M total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
61
Nilai yang dipegang
$65.5M
Posisi baru
11
Posisi yang keluar
7
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 11 (-4 vs Kuartal sebelumnya) | 7 (+4 vs Kuartal sebelumnya) | 31 (+13 vs Kuartal sebelumnya) | 9 (-2 vs Kuartal sebelumnya) | +5.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| HSG Holding Ltd | $24.714.470 | 3.750.299 | 37,75% | Saham |
| VANGUARD GROUP INC | $8.483.219 | 1.201.589 | 12,96% | Saham |
| BlackRock, Inc. | $6.550.085 | 993.943 | 10,01% | Saham |
| Octagon Capital Advisors LP | $6.289.601 | 954.416 | 9,61% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.778.949 | 876.927 | 8,83% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $3.513.176 | 532.950 | 5,37% | Saham |
| STATE STREET CORP | $1.617.199 | 245.402 | 2,47% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.214.445 | 184.286 | 1,86% | Saham |
| NORTHERN TRUST CORP | $1.117.249 | 169.537 | 1,71% | Saham |
| SBI Securities Co., Ltd. | $1.098.883 | 166.750 | 1,68% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $995.571 | 151.073 | 1,52% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $816.850 | 123.953 | 1,25% | Saham |
| GOLDMAN SACHS GROUP INC | $568.289 | 86.235 | 0,87% | Saham |
| Bank of New York Mellon Corp | $413.523 | 62.750 | 0,63% | Saham |
| MORGAN STANLEY | $274.743 | 41.691 | 0,42% | Saham |
| ALLIANCEBERNSTEIN L.P. | $171.392 | 24.590 | 0,26% | Saham |
| STRS OHIO | $170.022 | 25.800 | 0,26% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $166.516 | 25.268 | 0,25% | Saham |
| Nuveen, LLC | $161.488 | 24.505 | 0,25% | Saham |
| UBS Group AG | $123.649 | 18.763 | 0,19% | Saham |
| MILLENNIUM MANAGEMENT LLC | $121.836 | 18.488 | 0,19% | Saham |
| DEUTSCHE BANK AG\ | $118.218 | 17.939 | 0,18% | Saham |
| RHUMBLINE ADVISERS | $111.131 | 16.865 | 0,17% | Saham |
| WELLS FARGO & COMPANY/MN | $107.397 | 16.297 | 0,16% | Saham |
| FMR LLC | $98.679 | 14.974 | 0,15% | Saham |
| ROYAL BANK OF CANADA | $87.000 | 13.195 | 0,13% | Saham |
| BANK OF AMERICA CORP /DE/ | $82.539 | 12.525 | 0,13% | Saham |
| Polymer Capital Management (US) LLC | $77.630 | 11.780 | 0,12% | Saham |
| Vanguard Global Advisers, LLC | $65.788 | 9.983 | 0,10% | Saham |
| Police & Firemen's Retirement System of New Jersey | $59.382 | 9.011 | 0,09% | Saham |
| CITIGROUP INC | $56.582 | 8.586 | 0,09% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55.659 | 8.446 | 0,09% | Saham |
| JPMORGAN CHASE & CO | $50.510 | 7.831 | 0,08% | Saham |
| Russell Investments Group, Ltd. | $24.930 | 3.783 | 0,04% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $22.973 | 3.486 | 0,04% | Saham |
| BARCLAYS PLC | $21.273 | 3.228 | 0,03% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $17.793 | 2.700 | 0,03% | Saham |
| Tower Research Capital LLC (TRC) | $16.271 | 2.469 | 0,02% | Saham |
| Legal & General Group Plc | $13.536 | 2.054 | 0,02% | Saham |
| Ameritas Investment Partners, Inc. | $4.501 | 683 | 0,01% | Saham |
| Activest Wealth Management | $3.512 | 533 | 0,01% | Saham |
| Arax Advisory Partners | $1.621 | 246 | 0,00% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.094 | 166 | 0,00% | Saham |
| Sterling Capital Management LLC | $1.061 | 161 | 0,00% | Saham |
| GAMMA Investing LLC | $962 | 146 | 0,00% | Saham |
| CWM, LLC | $725 | 104 | 0,00% | Saham |
| Physician Wealth Advisors, Inc. | $541 | 82 | 0,00% | Saham |
| Bare Financial Services, Inc | $521 | 79 | 0,00% | Saham |
| GoalVest Advisory LLC | $367 | 50 | 0,00% | Saham |
| OSAIC HOLDINGS, INC. | $288 | 44 | 0,00% | Saham |
Aktivis & pemilik 5%+ 21 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Songjiang Ma, Yueying Zhu | 7 Mei 2026 | 6,33% | Amandemen | M&A / penjualan | SEC |
| Ying Luo, Ping Lan | 6 Mei 2026 | 8,60% | Amandemen | M&A / penjualan | SEC |
| GNI USA, Inc., GNI Group Ltd. ×4 pengajuan | 6 Mei 2026 | 69,10% | Amandemen | M&A / penjualan | SEC |
| Ying Luo (“Mr. Luo”), Ping Lan | 6 Sep. 2024 | · | Pengajuan awal | Investasi pasif | SEC |
| Songjiang Ma (“Mr. Ma”), Yueying Zhu | 6 Sep. 2024 | · | Pengajuan awal | Investasi pasif | SEC |
| GNI Group Ltd., GNI Hong Kong Limited, GNI USA, Inc. ×2 pengajuan | 31 Okt. 2023 | · | Pengajuan awal | · | SEC |
| JDS1, LLC, CCUR Holdings, Inc., CIDM II, LLC, Julian D. Singer, David S. Oros ×13 pengajuan | 7 Okt. 2022 | · | Pengajuan awal | Investasi pasif | SEC |
| JEC II Associates, LLC, The Heidi S. Shippell-Heiland 2008 Irrevocable Trust, Michael Torok ×4 pengajuan | 22 Sep. 2022 | · | Pengajuan awal | · | SEC |
| Julian Singer, JDS1, LLC 2, CCUR Holdings, Inc., David S. Oros ×3 pengajuan | 27 Jan. 2022 | · | Pengajuan awal | · | SEC |
| 22NW Fund, LP, 22 NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., Aron R. English ×2 pengajuan | 5 Agu 2020 | · | Pengajuan awal | · | SEC |
| CCUR Holdings, Inc., Wayne Barr, Jr., JDS1, LLC, David S. Oros, Julian Singer ×3 pengajuan | 17 Jan. 2020 | · | Pengajuan awal | · | SEC |
| Morgenthaler Management Partners VIII, LLC (“MMP VIII”), Morgenthaler Partners VIII, L.P. (“MP VIII”), Robert C. Bellas, Jr. (“Bellas”), Ralph E. Christoffersen (“Christoffersen”), John Lutsi (“Lutsi”), Gary J. Morgenthaler (“Morgenthaler”), Robert D. Pavey (“Pavey”), Gary R. Little (“Little”) | 14 Feb. 2018 | · | Pengajuan awal | · | SEC |
| HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, James H. Cavanaugh, Ph.D., Harold R. Werner, John W. Littlechild, Christopher Mirabelli, Ph.D., Augustine Lawlor ×2 pengajuan | 9 Feb. 2018 | · | Pengajuan awal | · | SEC |
| 23 Mei 2017 | · | Pengajuan awal | · | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, Michael James Barrett, Peter J. Barris, Scott D. Sandell ×4 pengajuan | 29 Maret 2017 | · | Pengajuan awal | · | SEC |
| Essex Woodlands Health Ventures VIII, LLC, Essex Woodlands Health Ventures VIII, L.P., Essex Woodlands Health Ventures Fund VIII, L.P., Jeff Himawan, Ph.D., James Currie, Martin Sutter, Immanuel Thangaraj, Petri Vainio, Ron Eastman, Steve Wiggins, Guido Neels | 31 Agu 2015 | · | Pengajuan awal | Investasi pasif | SEC |
| Morgenthaler Management Partners VIII, LLC, Morgenthaler Partners VIII, L.P., Ralph Christoffersen, Robert Bellas, John Lutsi, Gary Morgenthaler, Robert Pavey, Gary Little | 31 Agu 2015 | · | Pengajuan awal | Investasi pasif | SEC |
| Rosetta Capital V LP, Rosetta Capital V GP LP, Rosetta Capital V GP Limited, Rosetta Capital Limited | 28 Agu 2015 | · | Pengajuan awal | Investasi pasif | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BIOTECHNOLOGY VALUE FUND II, L.P., BVF INVESTMENTS, L.L.C., INVESTMENT 10, L.L.C., MSI BVF SPV, LLC, BVF PARTNERS, L.P., BFV INC., MARK N. LAMPERT ×6 pengajuan | 21 Agu 2015 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 29 Jan. 2008 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 28 Jan. 2008 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 66 orang dalam · 26 pejabat · 32 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Ying Luo | Chief Executive Officer | 8 Juni 2026 A | 2.565.226 | 0 | 2 | $-82.927 |
| Han Ying | Chief Executive Officer | 14 Agu 2024 A | · | 0 | 0 | $0 |
| Charles C Wu | Chief Executive Officer | 20 Nov. 2023 A | · | 0 | 0 | $0 |
| Donald J Debethizy | President and CEO | 4 Mei 2012 A | 798 | 0 | 0 | $0 |
| Thomas Wilson Eastling | Chief Financial Officer | 4 Mei 2026 A | 15.000 | 0 | 0 | $0 |
| Ruoyu Chen | Chief Financial Officer | 7 Jan. 2026 A | · | 0 | 0 | $0 |
| Seline E. Miller | SVP Finance; Interim CFO & PAO | 31 Agu 2023 D | 0 | 0 | 0 | $0 |
| Clinton Musil | Chief Financial Officer | 8 Feb. 2021 A | · | 0 | 0 | $0 |
| Fletcher Payne | Chief Financial Officer | 12 Agu 2019 A | 3.744 | 0 | 0 | $0 |
| Mauri K Hodges | Treasurer, CFO | 14 Agu 2015 A | 1.159 | 0 | 0 | $0 |
| Alan A Musso | SVP, Fin+Admin, CFO & Treas | 17 Okt. 2014 A | 57.799 | 0 | 0 | $0 |
| Songjiang Ma | President | 28 Mei 2025 S | 2.806.084 | 0 | 0 | $0 |
| Weiguo Ye | Chief Operating Officer | 18 Juni 2026 M | 700.000 | 0 | 16 | $-869.947 |
| Joshua Benjamin Bergmann | GC and Corporate Secretary | 8 Juni 2026 A | · | 0 | 0 | $0 |
| Grant E. Blouse | Chief Scientific Officer | 9 Agu 2022 P | 9.417 | 0 | 0 | $0 |
| Howard Levy | Chief Medical Officer | 9 Agu 2021 P | 639 | 0 | 0 | $0 |
| Veronica Cai | Controller | 13 Maret 2020 P | 7.353 | 0 | 0 | $0 |
| Edwin Madison | Chief Scientific Officer | 22 Okt. 2015 A | 31.008 | 0 | 0 | $0 |
| Patrick C. Rock | Secretary, GC | 14 Agu 2015 A | 45.000 | 0 | 0 | $0 |
| Steven M. Toler | VP, Clin Pharm Sciences | 17 Okt. 2014 A | 46.000 | 0 | 0 | $0 |
| David A. Hosford | VP, Clin Dev & Reg Affairs | 23 Jan. 2014 A | · | 0 | 0 | $0 |
| Karen A Hicks | VP, Human Resources | 17 Jan. 2013 A | 0 | 0 | 0 | $0 |
| Peter A Zorn | SVP, Lgl Affrs, GC & Secretary | 17 Jan. 2013 A | 0 | 0 | 0 | $0 |
| Merouane Bencherif | SVP and Senior Scien Fellow | 17 Jan. 2013 A | 15.938 | 0 | 0 | $0 |
| William S Caldwell | SVP - Drug Discovery and Dev. | 20 Sep. 2011 G | 500 | 0 | 0 | $0 |
| Geoffrey C Dunbar | SVP, Clin. Dev. & Reg. Affairs | 29 Maret 2011 A | 1.153 | 0 | 0 | $0 |
| Claire Weston | Direktur | 3 Agu 2026 A | · | 0 | 0 | $0 |
| Maxwell Kirkby | Direktur | 3 Agu 2026 A | · | 0 | 0 | $0 |
| Dan Weng | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| Ping Zhang | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| Rodney L Nussbaum | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| Renate Parry | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| Gordon Carmichael | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| David M. Epstein | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| Nassim Usman | Direktur | 28 Juni 2024 M | 1.636 | 0 | 0 | $0 |
| Andrea Hunt | Direktur | 31 Agu 2023 D | 0 | 0 | 0 | $0 |
| Augustine Lawlor | Direktur | 31 Agu 2023 D | 0 | 0 | 0 | $0 |
| Geoffrey Ling M.D. | Direktur | 7 Jan. 2022 A | 31.790 | 0 | 0 | $0 |
| Eddie Williams | Direktur | 7 Jan. 2022 A | 34.804 | 0 | 0 | $0 |
| Errol B Desouza | Direktur | 1 Okt. 2021 A | 29.801 | 0 | 0 | $0 |
| Jeanne Y Jew | Direktur | 9 Sep. 2021 A | · | 0 | 0 | $0 |
| Sharon Tetlow | Direktur | 9 Juni 2021 A | 3.635 | 0 | 0 | $0 |
| John P Richard | Direktur | 13 Maret 2020 P | 3.716 | 0 | 0 | $0 |
| Stephen A Hill | Direktur | 6 Sep. 2018 D | 1.190 | 0 | 0 | $0 |
| Harold E Selick | Direktur | 16 Jan. 2018 A | 16.614 | 0 | 0 | $0 |
| Jeff Himawan | Direktur | 20 Agu 2015 J | 1.179.352 | 0 | 0 | $0 |
| Alan W Dunton | Direktur | 14 Agu 2015 A | 10.000 | 0 | 0 | $0 |
| Charles A Blixt | Direktur | 14 Agu 2015 A | 10.000 | 0 | 0 | $0 |
| Julia R Brown | Direktur | 14 Agu 2015 A | 10.000 | 0 | 0 | $0 |
| SKALETSKY MARK B | Direktur | 7 Juni 2013 A | 11.332 | 0 | 0 | $0 |
| Steven Burrill | Direktur | 31 Juli 2012 M | 4.333 | 0 | 0 | $0 |
| Ralph Snyderman | Direktur | 7 Juni 2012 A | 0 | 0 | 0 | $0 |
| Ann Hanham | Direktur | 18 April 2006 C | 778.062 | 0 | 0 | $0 |
| GNI Hong Kong Ltd | Pemilik 10% | 27 Okt. 2023 J | 0 | 0 | 0 | $0 |
| Scott D. Sandell | Pemilik 10% | 5 Des. 2013 S | 0 | 0 | 0 | $0 |
| Peter J Barris | Pemilik 10% | 5 Des. 2013 S | 0 | 0 | 0 | $0 |
| James M Barrett | Pemilik 10% | 3 Des. 2013 M | 0 | 0 | 0 | $0 |
| Richard C Kramlich | Pemilik 10% | 19 Nov. 2012 X | 5.333 | 0 | 0 | $0 |
| NEA Partners 10, Limited Partnership | Pemilik 10% | 17 Jan. 2008 J | 4.563.512 | 0 | 0 | $0 |
| Iii Eugene A Trainor | Pemilik 10% | 17 Jan. 2008 J | 4.563.512 | 0 | 0 | $0 |
| New Enterprise Associates 10, Limited Partnership | Pemilik 10% | 17 Jan. 2008 J | 4.563.512 | 0 | 0 | $0 |
| Mark W Perry | Pemilik 10% | 17 Jan. 2008 J | 4.563.512 | 0 | 0 | $0 |
| Charles W Newhall III | Pemilik 10% | 17 Jan. 2008 J | 4.563.512 | 0 | 0 | $0 |
| Peter Morris | Pemilik 10% | 6 Feb. 2007 M | 2.000 | 0 | 0 | $0 |
| Jeffrey P Brennan | · | 17 Jan. 2013 A | 0 | 0 | 0 | $0 |
| Elaine V Jones | · | 29 Nov. 2007 X | 27.500 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 11 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWO · iShares Trust | 0,01% | 120.729 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,00% | 8.775 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 387.159 SH | 11 Sep. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 238.693 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 614.654 SH | 19 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 104.607 SH | 19 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.047 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.494 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 805 SH | 19 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 320 NS | 31 Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 41.397 SH | 11 Sep. 2026 | Harian |
GYRE Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 9 analis
BELI
Target median
$18.00
+153,2%
3 33,3%
Beli Kuat
5 55,6%
Beli
1 11,1%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
3 analis · 2026-10-02Target rata-rata $18.67 +162,5%
← Di bawah semua target
Harga saat ini $7.11
Rendah$18.00
Rata-rata$18.67
Tinggi$20.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| ACHV | · | -4.0 | · | · | · | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| FTH | · | · | · | · | · | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 7, 2026